Drug Report History #158881

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v15-FR Version v13-FR
Language French French
Date Updated 2023-02-21 (Updated) 2023-02-13
Drug Identification Number 02436221 02436221
Brand name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Company Name TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC. TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
Ingredients EPINEPHRINE LIDOCAINE HYDROCHLORIDE EPINEPHRINE LIDOCAINE HYDROCHLORIDE
Strength(s) 0.01MG 20MG 0.01MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 20mL vial 20mL vial
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-14 2022-04-14
Estimated end date 2023-02-16 2023-02-16
Actual end date 2023-02-16 (Updated)
Shortage status Resolved (Updated) Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments